Dr Tamara Maiuri
Editor
Hamilton, Ontario, Canada
Dr. Tamara Maiuri is a postdoctoral fellow in Dr. Ray Truant’s group at McMaster University, Canada. Prior to joining the Huntington’s disease field, Tamara obtained her PhD from the Medical Biophysics Department at the University of Toronto where she studied the cell biology of cancer-related genes. Her work in the Truant lab focuses on the normal biological functions of the huntingtin protein in hopes of understanding how they may be disrupted upon inheritance of the mutant huntingtin gene that causes HD.
Articles edited by Dr Tamara Maiuri
- 降低亨廷顿蛋白疗法汇总
- ASO药物HTT-RX 第一次试验完成,成功降低病人的突变蛋白水平
- 精准药物试验瞄准并降低突变蛋白
- 今日新闻发布确定亨廷顿舞蹈症'基因沉默'试验开始
- 新研究为我们带来了有潜力的HD生物标记物
- FDA批准治疗亨廷顿舞蹈症新药物
- 通过不寻常的案例,理解亨廷顿舞蹈症的发病和进展
- 早期HD蛋白接触可能造成长期症状
- 反思哪些大脑部位控制HD的早期症状
- 亨廷顿舞蹈症基因沉默药物的首次人体实验
- 在大脑的洗澡水中测量有害亨廷顿蛋白
- 带着目标去银行:DNA修复蛋白ATM在亨廷顿舞蹈症中过度活跃
- 亨廷顿舞蹈症临床实验声明:亨廷顿降低药物将于2015进入第一阶段实验